Clinical Trials Browser

Has results × Lymphoma, T-Cell, Cutaneous × tenalisib × Clear all

NCT02567656 2020-01-13

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Phase 1 Completed

58 enrolled 15 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral